Abliva - CEO Ellen Donnelly talks about the positive interim analysis in the FALCON study

(3:24)

Abliva | BioStock Life Science Summit 2024

(15:5)

BioStock Life Science Fall Summit | Abliva | October 2023

(13:37)

Abliva - Light Up for Mito during World Mitochondrial Disease Week 2024

(1:14)

Abliva leads the way with potential mitochondrial disease treatment

(12:12)

Abliva - About Lead Candidate KL1333

(2:16)

Abliva - Designing Therapies for Mitochondrial Disease - World Mitochondrial Disease Week

(2:16)

Abliva - Developing the PROMIS Fatigue Mitochondrial Disease Short Form

(2:42)

Abliva - Participating in the FALCON Study - World Mitochondrial Disease Week 2023

(2:20)

Abliva - Introducing Mitochondrial “Mito” Disease - World Mitochondrial Disease Week 2022

(2:32)

BioStock Investor Meeting | Abliva | March 2023

(18:36)

Abliva | BioStock Global Forum 2024

(15:15)

Ab Liva (Feat. Pusha T) - Who's Better (Official Video)

(3:33)

Ab Liva - The Sermon [HQ]

(3:43)

Abliva - Introducing the FALCON study - World Mitochondrial Disease Week

(2:31)

Abliva - World Mitochondrial Disease Week 2023

(28)

Abliva’s innovative drug development programs for primary mitochondrial diseases, M. Hansson

(15:52)

AstraZeneca CEO Soriot on Pharmaceuticals in China

(7:27)

Abliva - A Patient-Centric Approach to Drug Development - World Mitochondrial Disease Week 2022

(3:47)

Abliva - Review of Interim Analysis

(14:11)